Lonza and Patheon extend exclusivity period; explore transaction options

NewsGuard 100/100 Score

Lonza Group AG ("Lonza") and the Special Committee of Independent Directors of Patheon Inc. ("Patheon" or the "Company") (TSX:PTI) today announced the extension of the exclusivity period granted to Lonza by Patheon, which had been scheduled to expire today. The extension allows for continued discussions regarding possible strategic transactions between Patheon and Lonza. The period of exclusivity will continue until terminated by either party by notice to the other. Other terms of the exclusivity arrangements will continue to apply.

Lonza and Patheon are continuing to explore various strategic options that are in the best interests of the two companies. In view of the announced position of JLL Patheon Holdings LLC ("JLL") that it is not prepared to sell its shares of Patheon at this time, these discussions include potential transactions that do not require the sale of JLL's shares. There can be no assurance that any transaction involving the Company and Lonza will be completed or as to the terms of any such transaction.

Source: PATHEON INC.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.